We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBF icon
226
PBF Energy
PBF
$8.05B
$886K 0.15%
21,726
-48,659
-69% -$2.02M
VST icon
227
Vistra
VST
$48.3B
$885K 0.15%
+38,143
New +$883K
MMS icon
228
Maximus
MMS
$3.27B
$883K 0.15%
12,035
+1,869
+18% +$121K
QGEN icon
229
Qiagen
QGEN
$8.73B
$860K 0.15%
16,255
+10,684
+192% +$527K
PGR icon
230
Progressive
PGR
$122B
$859K 0.15%
6,621
-9,878
-60% -$1.25M
PK icon
231
Park Hotels & Resorts
PK
$3.04B
$857K 0.15%
72,731
-6,086
-8% -$74.2K
DLO icon
232
dLocal
DLO
$4.5B
$853K 0.14%
+54,781
New +$963K
SAM icon
233
Boston Beer
SAM
$1.94B
$850K 0.14%
2,578
+255
+11% +$92.5K
LBRDK icon
234
Liberty Broadband Class C
LBRDK
$4.86B
$848K 0.14%
11,118
+2,738
+33% +$223K
AYI icon
235
Acuity Brands
AYI
$10B
$841K 0.14%
+5,078
New +$902K
AMR icon
236
Alpha Metallurgical Resources
AMR
$1.76B
$835K 0.14%
5,705
+1,321
+30% +$209K
SMG icon
237
ScottsMiracle-Gro
SMG
$3.97B
$824K 0.14%
+16,964
New +$850K
ORI icon
238
Old Republic International
ORI
$10.5B
$818K 0.14%
33,878
+5,739
+20% +$135K
SNPS icon
239
Synopsys
SNPS
$77.3B
$813K 0.14%
2,546
-2,319
-48% -$726K
ARW icon
240
Arrow Electronics
ARW
$11.1B
$812K 0.14%
7,761
-1,719
-18% -$177K
RIG icon
241
Transocean
RIG
$5.78B
$803K 0.14%
+176,000
New +$679K
OSH
242
DELISTED
Oak Street Health, Inc.
OSH
$800K 0.14%
37,202
+7,534
+25% +$158K
KLAC icon
243
KLA
KLAC
$255B
$799K 0.14%
+21,180
New +$738K
PGNY icon
244
Progyny
PGNY
$2.47B
$793K 0.13%
25,448
+367
+1% +$13.3K
JAZZ icon
245
Jazz Pharmaceuticals
JAZZ
$15.8B
$788K 0.13%
4,946
+3,192
+182% +$468K
TFX icon
246
Teleflex
TFX
$6.18B
$784K 0.13%
3,139
-1,396
-31% -$308K
VC icon
247
Visteon
VC
$2.82B
$774K 0.13%
+5,913
New +$788K
HIG icon
248
Hartford Financial Services
HIG
$39.2B
$760K 0.13%
10,020
-5,961
-37% -$429K
MTD icon
249
Mettler-Toledo International
MTD
$29B
$757K 0.13%
524
+149
+40% +$199K
FOXA icon
250
Fox Class A
FOXA
$24.6B
$756K 0.13%
+24,880
New +$759K
8 9
10
11 12

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.